0.0420
+0.0010
+(2.44%)
At close: 3:42:49 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-7,397.9070
-7,397.9070
-6,191.0030
-4,312.6570
-3,970.0250
Investing Cash Flow
12,000
12,000
-16,000
-4.4290
-2.3140
Financing Cash Flow
18.1500
18.1500
15,828.3280
428.2930
12,749.7140
End Cash Position
10,493.1830
10,493.1830
5,895.4300
12,263.8390
16,097.5080
Capital Expenditure
--
--
--
-4.4290
-2.3140
Issuance of Capital Stock
18.1500
18.1500
16,526.1460
594.1220
13,577.3170
Repayment of Debt
--
--
--
-165.8290
8.9490
Repurchase of Capital Stock
--
--
--
--
-836.5520
Free Cash Flow
-7,397.9070
-7,397.9070
-6,191.0030
-4,317.0860
-3,972.3390
6/30/2021 - 1/28/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNV.AX RENERVE FPO [RNV]
0.1100
-4.35%
PAB.AX Patrys Limited
0.0020
0.00%
IMC.AX Immuron Limited
0.0670
+1.52%
NUZ.AX Neurizon Therapeutics Limited
0.1050
+6.06%
BIT.AX Biotron Limited
0.0020
-33.33%
CUS0.BE Curis Inc. R
1.0100
-7.34%
BTC.AX BTC Health Limited
0.0500
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0350
0.00%
IXC.AX Invex Therapeutics Ltd
0.0700
0.00%
TRP.AX Tissue Repair Ltd
0.2350
-4.08%